semaglutide is it a peptide of the Week: Peptide: Promising Advancement in Diabetes Treatment Semaglutide | Peak Biosciences

Survodutide Survodutide combines GLP-1 and glucagon receptor agonism and may offer benefits for both obesity and metabolic-associated steatotic liver disease

GLP-1 medications reduce hunger powerfully but without nutrition support, companion and habit guidance, most people regain the weight.

The hormonal mechanism, timeline, and evidence-based strategies for managing it long-term.

What are the effects of bimagrumab, an antibody that blocks activin type II receptors and stimulates skeletal muscle growth, on total body fat mass and glycemic control in patients with type 2 diabetes and excess adiposity

The rise of GLP-1 weight-loss drugs is shifting consumer habits

Inflammatory bowel diseases (IBD), including Crohns disease (CD) and ulcerative colitis (UC), are chronic, relapsing, intestinal inflammatory disorders with complex and yet unrevealed pathogenesis in which genetic, immunological, and environmental factors play a role